NPI: 1154398279 · LEHIGH ACRES, FL 33971 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,942 | $1.77M |
| 2019 | 16,147 | $3.24M |
| 2020 | 20,320 | $3.21M |
| 2021 | 12,760 | $925K |
| 2022 | 5,927 | $769K |
| 2023 | 3,264 | $318K |
| 2024 | 3,030 | $120K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,449 | 1,060 | $3.79M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,341 | 1,565 | $3.07M |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,339 | 815 | $1.66M |
| A4657 | Syringe, with or without needle, each | 2,403 | 962 | $575K |
| J1756 | Injection, iron sucrose, 1 mg | 4,390 | 792 | $568K |
| 85041 | 967 | 649 | $155K | |
| 85048 | 965 | 648 | $154K | |
| 83970 | 840 | 536 | $141K | |
| 82728 | 583 | 388 | $91K | |
| 83540 | 592 | 392 | $88K | |
| 83550 | 322 | 198 | $46K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 85 | 51 | $10K |
| 90674 | 17 | 13 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 25 | 16 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 72 | 24 | $4K |